Skip to main content
. 2021 Apr 15;21:576. doi: 10.1186/s12889-021-10606-1

Table 4.

Risk of CVD outcomes and mortality associated with BMI trajectory groups

Unadjusted Hazards ratio (95% CI) Adjusted hazards ratio (95% CI)
CVD outcome Trajectory group Model adjusted for age and sex Model adjusted for age, sex and comorbiditiesa
Overall CVD overweight-S 1.00 1.00 1.00
obese 1-S 1.25 (1.22–1.28) 1.24 (1.21–1.28) 1.15 (1.12–1.19)
obese 2-S 1.32 (1.28–1.36) 1.46 (1.41–1.51) 1.27 (1.23–1.31)
obese 3-S 1.42 (1.35–1.50) 1.75 (1.66–1.85) 1.40 (1.33–1.48
Coronary heart disease overweight-S 1.00 1.00 1.00
obese 1-S 1.23 (1.19–1.28) 1.23 (1.18–1.27) 1.14 (1.10–1.18)
obese 2-S 1.17 (1.12–1.22) 1.30 (1.24–1.35) 1.13 (1.09–1.18)
obese 3-S 1.07 (0.99–1.16) 1.31 (1.22–1.42) 1.06 (0.99–1.16)
Stroke/ TIA overweight-S 1.00 1.00 1.00
obese 1-S 1.18 (1.12–1.24) 1.16 (1.10–1.22) 1.09 (1.03–1.15)
obese 2-S 1.16 (1.09–1.24) 1.27 (1.19–1.36) 1.13 (1.06–1.20)
obese 3-S 1.04 (0.93–1.18) 1.26 (1.12–1.42) 1.04 (0.92–1.18)
Peripheral vascular disease overweight-S 1.00 1.00 1.00
obese 1-S 1.13 (1.05–1.22) 1.13 (1.04–1.22) 0.99 (0.92–1.07)
obese 2-S 1.02 (0.92–1.12) 1.16 (1.06–1.29) 0.92 (0.83–1.01)
obese 3-S 0.79 (0.65–0.96) 1.03 (0.85–1.25) 0.73 (0.60–0.89)
Heart failure overweight-S 1.00 1.00 1.00
obese 1-S 1.73 (1.63–1.83) 1.73 (1.63–1.83) 1.51 (1.42–1.60)
obese 2-S 2.31 (2.16–2.46) 2.70 (2.53–2.88) 2.09 (1.96–2.23)
obese 3-S 3.58 (3.28–3.91) 4.94 (4.53–5.40) 3.26 (2.98–3.57)
All-cause mortality overweight-S 1.00 1.00 1.00
obese 1-S 1.16 (1.13–1.20) 1.16 (1.12–1.19) 1.12 (1.09–1.16)
obese 2-S 1.41 (1.36–1.46) 1.63 (1.58–1.69) 1.55 (1.50–1.61)
obese 3-S 2.17 (2.06–2.29) 2.96 (2.81–3.12) 2.72 (2.58–2.87)
CVD-related deaths overweight-S 1.00 1.00 1.00
obese 1-S 1.53 (1.40–1.68) 1.54 (1.40–1.68) 1.44 (1.31–1.58)
obese 2-S 1.94 (1.75–2.15) 2.33 (2.10–2.59) 2.06 (1.86–2.29)
obese 3-S 2.73 (2.35–3.17) 3.98 (3.42–4.63) 3.31 (2.84–3.86)

Trajectory group 1 (overweight-stable) used as baseline group for comparison

a Multivariate cox regression models adjusted for age, sex, hypertension, type 2 diabetes, atrial fibrillation and chronic kidney disease